Agent |
Dosage |
|
Statins |
||
Atorvastatin |
10-80 mg once daily |
|
Fluvastatin |
20-80 mg once daily |
|
Lovastatin |
20-80 mg once daily |
|
Rosuvastatin |
5-40 mg once daily |
|
Simvastatin |
5-80 mga once daily |
|
Pitavastatin (not used in Canada) |
1-4 mg once daily |
|
Cholesterol absorption inhibitor |
||
Ezetimibe |
10 mg once daily |
|
Fibrates |
||
Bezafibrate |
400 mg once daily |
|
Gemfibrozil |
600 mg bid |
|
Fenofibrate |
Nonmicronized |
48 mg, 145 mg, 54 mg, 160 mg, or 67 mg once daily with main meal |
Micronized |
200 mg, 134 mg, 40 mg, 120 mg, 43 mg, 130 mg, 30 mg, 90 mg, 50 mg, or 150 mg once daily with main meal |
|
PCSK9 inhibitors |
||
Alirocumab |
75 mg SC every other week, 150 mg SC every 2 weeks, or 300 mg every 4 weeks |
|
Inclisiran |
– Initial dose: 284 mg SC once, and repeat in 3 months – Maintenance dose (after initial dose): 284 mg SC every 6 months |
|
Evolocumab (no longer used in Canada) |
140 mg SC every 2 weeks or 420 mg once monthly |
|
Omega-3 acid |
||
Icosapent ethyl |
2 g bid |
|
Bile acid sequestrants (resins) |
||
Cholestyramine |
Start from 4 g once daily to bid, then titrate up to 4 g/d (max, 24 g/d in divided doses) |
|
Colesevelam |
1.875 g bid or 3.75 g once daily |
|
a Note: The US Food and Drug Administration does not recommend the use of simvastatin at a dose of 80 mg/d because of increased incidence of myopathy. |
||
Bid, twice a day; PCSK9, proprotein convertase subtilisin/kexin type 9; SC, subcutaneous. |